桂林莱茵生物科技股份有限公司关于股东部分股份解除质押及再质押的公告

Group 1 - The core point of the announcement is that the major shareholder, Mr. Qin Benjun, has completed the procedures for the partial release and re-pledging of his shares in the company [1] - Mr. Qin plans to transfer 60 million shares, representing 8.09% of the company's total share capital, to Guangzhou Defu Nutrition Investment Partnership through a share transfer agreement [2] - The pledged shares are not intended for new financing or to meet the company's operational needs [3] Group 2 - As of the announcement date, Mr. Qin's total pledged shares and their respective proportions are detailed, indicating no risk of forced liquidation [3] - The company will continue to monitor changes in the shareholder's equity and potential disposal risks, ensuring timely disclosure obligations are met [3]